Accessibility Menu
Paion Ag logo

Paion Ag(OTC) PAIOF

Current Price$0.07
Market Cap$499.40KMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2005)-100%
5 Year-100%
1 Year+600%
1 Month+600%
Paion Ag last closing stock price
MetricPriceDate
Last closeUSD 0.072026-07-16
Paion Ag stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+600%USD 0.012026-04-30
1 month+600%USD 0.012026-04-30
3 month+600%USD 0.012026-04-13
Year to date+600%USD 0.012025-12-30
1 year+600%USD 0.012025-05-12
3 year-92.55%USD 0.942023-07-11
5 year-99.69%USD 22.402021-07-12
Since inception-99.92%USD 91.502005-12-05

Paion Ag Financials at a Glance

Market Cap

$499.40KMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

€16.31M

Net Income (TTM)

-€26.50M

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

-3.38 (Low)

Price

$0.07

Volume

350

Open

$0.07

Previous Close

$0.07

Daily Range

$0.07 - $0.07

52-Week Range

$0.00 - $0.07

Estimated Earnings Date

Sep 2, 2026

PAIOF News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Paion Ag

Paion AG is a specialized biopharmaceutical company focused on developing and commercializing medications for hospital settings, particularly in sedation, anesthesia, and critical care management. The company is headquartered in Aachen, Germany, and operates globally, with a strong emphasis on innovative treatments.

Products and Services
  • Remimazolam: An ultra-short-acting intravenous sedative and anesthetic
  • Angiotensin II: A vasoconstrictor for refractory low blood pressure
  • Eravacycline: A novel antibiotic for complicated intra-abdominal infections
Growth Outlook
  • Recent partnerships enhance market access and product development
  • Ongoing clinical trials for Remimazolam show promising results
  • Expansion into critical care markets presents significant revenue potential
Financial Highlights
  • Q2 2023 revenue of €4.524 million, up from €3.395 million in Q1 2023
  • Gross profit margin improved to 33.2% in Q2 2023
  • Cash and cash equivalents of €4.647 million as of June 30, 2023
Paion AG is positioned in a niche market with a focus on innovative therapies that address critical medical needs. The company's lead product, Remimazolam, is undergoing clinical trials, which could significantly impact its future revenue streams. Recent financial performance indicates a positive trend, with increasing revenue and improving gross profit margins. Strategic partnerships further bolster the company's growth potential, making it an intriguing option for investors interested in the biopharmaceutical sector.
AI Generated • Jul 16, 2026

Industry

Biotechnology

Employees

70

CEO

Gregor Siebert

Website

paion.com

Headquarters

Aachen, NW 52078, DE

PAIOF Financials

Key Financial Metrics (TTM)

Gross Margin

94.10%

Operating Margin

4.53%

Net Income Margin

-1.74%

Return on Equity

-8.51%

Return on Capital

5.58%

Return on Assets

-1.52%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$499.40KMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

7.13M

Volume

350

Avg. Volume

7.903

Financials (TTM)

Gross Profit

€10.20M

Operating Income

-€22.37M

EBITDA

-€13.50M

Operating Cash Flow

-€6.05M

Capital Expenditure

-€954.38K

Free Cash Flow

-€7.01M

Cash & ST Invst.

€4.65M

Total Debt

€21.25M

Paion Ag Performance Analysis

Paion Ag annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20212021-12-31EUR 8,425,592N/A
20222022-12-31EUR 34,942,794314.7%
Paion Ag sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32022-09-30-90.0%
Q42022-12-312061.2%
Q12023-03-31-57.7%
Q22023-06-3033.3%
Paion Ag annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20212021-12-31EUR -3.68N/A
20222022-12-31EUR -0.09-97.7%
Paion Ag sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32022-09-30-50.0%
Q42022-12-31-37.1%
Q12023-03-3152.8%
Q22023-06-307.4%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2023YOY CHG

Revenue

€4.52M

+21.4%

Gross Profit

€1.50M

-59.5%

Gross Margin

33.24%

N/A

Market Cap

$499.40KMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$7.80K

N/A

Employees

64

N/A

Net Income

-€4.47M

-16.4%

EBITDA

-€3.30M

-36.3%

Quarterly Fundamentals

Name
Q2 2023YOY CHG

Total Cash

€4.65M

-73.7%

Total Debt

€21.25M

+4.3%

Accounts Receivable

€1.85M

+1625.2%

Inventory

€4.28M

+1.2%

Long Term Debt

€18.48M

-2.5%

Short Term Debt

€2.77M

+93.0%

Return on Assets

-1.52%

N/A

Return on Invested Capital

5.89%

N/A

Free Cash Flow

-€2.94K

-100.0%

Operating Cash Flow

-€2.94K

-100.0%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
CATV4Cable TV International, Inc.
$0.00+0.00%
CSUICannabis Suisse Corp.
$0.01+0.00%
IDCNIndocan Resources Inc.
$0.00+0.00%
NGMCNext Generation Management Corp.
$0.10+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
NOKNokia
$9.10-0.06%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$7.42-0.04%
ONDSOndas
$7.80-0.02%
SOFISoFi Technologies
$16.46-0.01%

Questions About PAIOF

What is the current price of Paion Ag?

Paion Ag is trading at $0.07 per share.

What is the 52-week range for Paion Ag?

Over the past 52 weeks, Paion Ag has traded between $0.00 and $0.07.

How much debt does Paion Ag have?

As of the most recent reporting period, Paion Ag reported total debt of €21.72M.

How much cash does Paion Ag have on hand?

Paion Ag reported €11.34M in cash and cash equivalents in its most recent financial results.

What is Paion Ag’s dividend yield?

Paion Ag does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.